Method for obtaining efficient viral vector-based compositions for vaccination or gene therapy
AssigneeLeukocare AG
InventorsKristina Kemter, Martin Scholz
Life of this patent
Estimating the term…
Loading patent…
AssigneeLeukocare AG
InventorsKristina Kemter, Martin Scholz
Estimating the term…
The present invention relates to a method for preparing viral vector-based compositions wherein the viral vector-based particles present in the composition have a particle size distribution with a polydispersity index (PDI) of less than 0.5, the method comprising the steps: (a) providing replication-deficient viral vectors; (b) providing a solution comprising at least one sugar and at least three different excipients selected from hydrophilic and amphiphilic excipients, wherein the excipients are characterized by polar, aliphatic, aromatic, negatively charged, and/or positively charged functional groups, and wherein the solution is further characterized by an excipient-sugar ratio of at least 1:2 (w/w); and (c) mixing the replication deficient viral vectors of step (a) with the solution of step (b). The present invention further relates to a viral vector-based composition obtainable by the method of the invention as well as to the viral vector-based composition of the invention for use as a prime-boost vaccine.
A method for preparing liquid compositions comprising modified viruses for storage, wherein the modified viruses present in the composition are used to deliver genetic material into cells, the method comprising the steps:
Dependencies are inferred from the claim text.